Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
Staffing Portal: The 2026 Complete Guide
Around 70 percent of mid-sized staffing firms and a growing share of large enterprises now run at least part of their contingent workforce operations through a staffing portal.The reason is…
Online Employee Portal: The 2026 Complete Guide
The HR technology market is expected to reach $47.51 billion by 2026, growing steadily in the coming years. In India, it is projected to hit $2,300 million by 2033.A large part of this investment is…
HCM Employee Self-Service: The 2026 Complete Guide
Organizations are losing $8.8 trillion annually to employee disengagement. That represents nearly 9 percent of global GDP.At the center of most solutions sits the HCM employee self-service portal. It…
Internal Portal for Employees: The 2026 Guide
The global employee experience management market has reached $7.1 billion in 2026. Organizations have spent heavily on digital workplace tools, AI integrations, and portal upgrades.Yet most internal…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
